TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).

Junzo Hamanishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.